Life Science Compliance Update



This Isn’t Walmart: The Supreme Court Narrows Forum-Shopping Options

Written by , Posted in Tort reform

Kaitlin Fallon Wildoner, Esq., Senior Staff Writer, Life Science Compliance Update

In a decision of great import to pharmaceutical and device companies, the Supreme Court ruled in favor of Bristol-Myers Squibb in a jurisdictional argument at the nation’s Highest Court. This article outlines the background, the case decision, and the decision’s ramifications to companies.

 To purchase the complete August 2017 issue of LSCU, Click here.

Topic tags:

Gravityscan Badge
Menu Title